ClinicalTrialsFinder

Tumor Thrombus Clinical Trials in Jinan, Shandong

1 recruitingJinan, Shandong, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

BITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + SBRT for BCLC-C HCC With PVTT and/or Oligometastases

Hepatocellular CarcinomaRadiotherapyImmunotherapy+3 more
Shandong Cancer Hospital and Institute54 enrolled1 locationNCT07062055